Adisseo and Allozymes forge partnership to revolutionise animal feed ingredient production 

FRANCE – Adisseo, one of the world’s leading experts in feed additives, has announced a strategic partnership with biotech innovator Allozymes to revolutionise the production of feed ingredients through cutting-edge bioprocesses. 

This marks one of Allozymes’ first European partnerships following its recent expansion into the region.

The partnership will focus on developing novel, environmentally friendly processes for producing methionine, an essential amino acid critical for animal health, growth, and performance. 

Traditionally, methionine production has relied on chemical processes with a considerable environmental footprint. 

However, Allozymes’ advanced technology offers a promising alternative. It harnesses the power of engineered enzymes to create more efficient and sustainable manufacturing processes.

Allozymes’ proprietary microfluidics platform, which allows for the rapid design, screening, and optimisation of millions of enzyme candidates simultaneously, will be at the heart of this initiative. 

Unlike traditional protein engineering methods, which are slow and labour-intensive, Allozymes’ system can quickly identify and optimise enzymes that meet specific production needs, significantly accelerating the development timeline.

“Our microfluidics platform allows us to analyse and optimise millions of enzyme variations concurrently quickly. This agility is crucial for developing customised enzymes that meet the specific needs of our partners, like Adisseo, faster and more efficiently,” said Akbar Vahidi, Chief Technology Officer of Allozymes.

The partnership is particularly timely, coinciding with Allozymes’ recent expansion into Europe, seeking to address the global market’s growing demand for bio-solutions in animal feed production.

“By collaborating with a global leader in the feed additives sector, we can directly address the global market’s need for bio-solutions in animal feed production. Our innovative enzymatic platform, combined with Adisseo’s expertise, has the potential to create a significant positive impact at a much faster rate,” said Peyman Salehian, CEO of Allozymes.

Jean-François Rous, Executive Vice President of Innovation at Adisseo, echoed this enthusiasm, stating, “The partnership with Allozymes represents a major step forward in our ongoing commitment to sustainable practices. Allozymes’ innovative microfluidics technology holds immense potential to transform our productions, allowing us to meet the growing demand for animal nutrition while minimising our environmental footprint.”

This collaboration builds on a previously successful partnership between the two companies, where Allozymes’ platform was used to enhance a key enzyme in a synthetic metabolic pathway developed by Adisseo. 

By screening millions of enzyme variants, Allozymes could identify a candidate that exceeded expectations, completing the project well ahead of schedule.

Sign up to receive our email newsletters with the latest news updates and insights from Africa and the World HERE.